Table 8.
Predictive values for soluble CD44, CD44v6, CD44v8-10 and EpCAM for predicting CCA recurrence using the optimal cut-off derived from the ROC curve in early stage of CCA patients
| Variables | AUC (95% CI) | Cut-off | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | p |
|---|---|---|---|---|---|---|---|
| CD44 | 0.670 (0.521–0.819) | 0.505 | 68.0 | 63.0 | 51.7 | 77.4 | 0.029 |
| CD44v6 | 0.670 (0.529–0.811) | 0.814 | 68.0 | 68.0 | 55.6 | 78.8 | 0.029 |
| CD44v8-10 | 0.702 (0.563–0.841) | 0.713 | 73.0 | 71.0 | 59.3 | 81.8 | 0.010 |
| EpCAM | 0.739 (0.598–0.880) | 0.506 | 68.0 | 76.0 | 62.5 | 80.6 | 0.002 |
CD44 cluster of differentiation 44, CD44v CD44 variant, EpCAM epithelial cell adhesion molecules, AUC area under curve, 95% CI 95% confidence interval, PPV positive predictive value, NPV negative predictive value